{
 "name": "華宇藥",
 "slug": "tw-6621",
 "aliases": [
  "華宇藥品股份有限公司",
  "UniPharma",
  "6621"
 ],
 "ticker": "6621",
 "industry": "生技醫療業",
 "website": "https://www.uni-pharma.com.tw/",
 "summary": "華宇藥（6621）是興櫃的生技醫療類股公司，1999 年成立，2017 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "華宇藥品股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "UniPharma",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2017-08-18",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "1999-12-23",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "鄭明聰",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "戴國明",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 355010000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "https://www.uni-pharma.com.tw/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：CASTOMIZE（輕量透氣自塑科技石膏）",
   "value": "骨折固定｜已推出代理商品｜台灣",
   "unit": "",
   "as_of": "2025-09-09",
   "source": "https://uni-pharma.com.tw/launch-castomize/",
   "note": "官網2025-09-09新品公告；用途為骨折固定，不以ISO13485或廠商宣稱代替TFDA許可證。"
  },
  {
   "claim": "管線：Anti-NMDAR抗體定量檢測（流式細胞儀）",
   "value": "NMDAR相關自體免疫疾病之臨床診斷及治療監測｜已提供檢測資訊與收檢需求｜台灣",
   "unit": "",
   "as_of": "2026-05-19",
   "source": "https://uni-pharma.com.tw/anti-nmdar-antibody-quantitative-test-info/",
   "note": "官網2026-05-19新推檢測頁；檢體為血清或腦脊髓液。此為檢測服務，非核准新藥。"
  },
  {
   "claim": "管線：內毒素檢驗（實驗室檢測服務）",
   "value": "內毒素檢驗｜實驗室公告可受理檢驗需求｜台灣",
   "unit": "",
   "as_of": "2026-03-20",
   "source": "https://uni-pharma.com.tw/mlb_taf/",
   "note": "官網2026-03-20公告列有內毒素、黴漿菌、自體免疫神經抗體檢驗需求。未將實驗室TAF認證當成逐項TFDA醫材許可；逐品許可字號及核准日查無。"
  },
  {
   "claim": "管線：黴漿菌檢驗（實驗室檢測服務）",
   "value": "黴漿菌檢驗｜實驗室公告可受理檢驗需求｜台灣",
   "unit": "",
   "as_of": "2026-03-20",
   "source": "https://uni-pharma.com.tw/mlb_taf/",
   "note": "官網2026-03-20公告列有內毒素、黴漿菌、自體免疫神經抗體檢驗需求。未將實驗室TAF認證當成逐項TFDA醫材許可；逐品許可字號及核准日查無。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6621.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}